| 中文名 | TAK-981 |
|---|---|
| 英文名 | TAK-981 |
| 中文别名 | ((1R,2S,4R)-4-((5-(4-((R)-7-氯-1,2,3,4-四氢异喹-1-基)-5-甲基噻吩-2-羰基)嘧啶-4-基)氨基)-2-羟基环戊基)氨基磺酸甲酯 |
| 英文别名 |
Subasumstat (TAK-981) ,S8829
Sulfamic acid, [(1R,2S,4R)-4-[[5-[[4-[(1R)-7-chloro-1,2,3,4-tetrahydro-1-isoquinolinyl]-5-methyl-2-thienyl]carbonyl]-4-pyrimidinyl]amino]-2-hydroxycyclopentyl]methyl ester Subasumstat, 10 mM in DMSO (1R,2S,4R)-4-{[5-({4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methyl-2-thienyl}carbonyl)pyrimidin-4-yl]amino}-2-hydroxycyclopentyl]methyl sulfamate MFCD32062692 inhibit,Ubiquitin ligase,E1/E2/E3 Enzyme,Subasumstat,TAK 981,E1 activating enzyme,Ubiquitin conjugating enzyme,Inhibitor,E2 conjugating enzyme,TAK981,Ubiquitin activating enzyme,E3 ligating enzyme Subasumstat Subasumstat(TAK-981) (1R,2S,4R)-4-[[5-[4-[(1R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate ((1R,2S,4R)-4-((5-(4-((R)-7-Chloro-1,2,3,4-tetrahydroisoquinolin-1-yl)-5-methylthiophene-2-carbonyl)pyrimidin-4-yl)amino)-2-hydroxycyclopentyl)methyl sulfamate |
| 描述 | TAK-981 是一线的、SUMOylation 酶联反应的选择性抑制剂,具有潜在的免疫激活和抗肿瘤活性。 |
|---|---|
| 相关类别 | |
| 靶点 |
SUMOylation[1]. |
| 体外研究 | TAK-981能够增加1型干扰素(IFN)的产生,从而增加1型IFN介导的信号传导,激活先天效应细胞并增强抗肿瘤先天免疫反应[1]。 |
| 体内研究 | 在肱动脉淋巴结处的幼稚Balb/c小鼠中单次皮下注射TAK-981诱导DC的激活[2]。 |
| 参考文献 |
[1]. Sumoylation inhibitor TAK-981. [2]. TAK-981. |
| 密度 | 1.474±0.06 g/cm3(Predicted) |
|---|---|
| 沸点 | 836.1±75.0 °C(Predicted) |
| 分子式 | C25H28ClN5O5S2 |
| 分子量 | 578.10 |
| 储存条件 | 2-8°C |
| 危害码 (欧洲) | Xi |
|---|